Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.

Ajay K SinghKevin CarrollVlado PerkovicScott SolomonVivekananda JhaKirsten L JohansenRenato D LopesIain C MacdougallGregorio T ObradorSushrut S WaikarChristoph WannerDavid C WheelerAndrzej WięcekAllison BlackorbyBorut CizmanAlexander R CobitzRich DaviesJo DoleLata KlerAmy M MeadowcroftXinyi ZhuJohn Joseph Valentine McMurraynull null

Published in: The New England journal of medicine (2021)

Among patients with CKD undergoing dialysis, daprodustat was noninferior to ESAs regarding the change in the hemoglobin level from baseline and cardiovascular outcomes. (Funded by GlaxoSmithKline; ASCEND-D ClinicalTrials.gov number, NCT02879305.).

Keyphrases

chronic kidney disease
end stage renal disease
patients undergoing
replacement therapy